Clinical trial
Impact of Molecular Microbiology Integrated With Clinical Data on Antimicrobial Therapy Optimization: An Open-Label Cluster-Randomized Crossover Trial
NCT07684300 is registered in ClinicalTrials.gov with Maria Espinosa Perez as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Molecular Microbiology Integrated With Clinical Data on Antimicrobial Therapy Optimization: An Open-Label Cluster-Randomized Crossover Trial
- Lead sponsor
- Maria Espinosa Perez
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 10, 2026
- Completion date
- June 30, 2027
- Enrollment
- 250 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antimicrobial resistance, antimicrobial stewardship program, infection, multiplex pcr